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LOOP ILEOSTOMY
A. Ewing 1,*, K. Brown 2, M. Dunlop 1. 1NHS Lothian, Edinburgh, UK; 2 The
University of Edinburgh, Edinburgh, UK.
Aim: Defunctioning loop ileostomy (DLI) is widely used as a component of
various resectional procedures to reduce or ameliorate anastomotic
leakage. However, the effectiveness of routine DLI remains unproven and
reversal is associated with procedure-speciﬁc complications and hospital
stay. We aim to describe the nature, rate of complications and hospital stay
after DLI closure.
Method: The department database was queried and charts reviewed for all
patients who underwent DLI closure in the 12-year period from January
2004 to November 2015.
Result: There were 421 patients who underwent DLI closure (median age
61 yrs, range 17-98yrs). Length of hospital stay after Ileostomy closure was
0-17 days, median¼ 8 days with a total bed usage of 3423 days. Signiﬁcant
complications arose in 79 patients (18.76%) with 14 requiring re-operative
intervention (3.33%). 33 developed a post-operative ileus. C. difﬁcile
infection arose in 9 cases andMRSA in 5.17 patients were re-admittedwith
a total stay of 48 nights.
Conclusion: This study describes an appreciable morbidity (18.76%) and
bed-day requirement associated with DLI closure. The ﬁndings inform
discussion around the role and value of defunctioning ileoanal and
coloanal anastomosis. The ﬁndings also provide useful data in the
consideration of an appropriately-powered RCT of ileoanal and coloanal
anastomosis.http://dx.doi.org/10.1016/j.ijsu.2016.08.156
0709: DESMOID TUMOURS AND FAMILIAL ADENOMATOUS POLYPOSIS:
OUR ROYAL EXPERIENCE
E. Kane 1,*, E. Garforth 1, R. Heath 1, A. Fryer 2, P. Rooney 1. 1Department of
Colorectal Surgery, Royal Liverpool University Hospital, Liverpool, UK;
2Department of Genetics, Liverpool Women's Hospital, Liverpool, UK.
Aim: Desmoid tumours are rare, non-metastasising ﬁbromatoses that
affect 8-23% of patients with FAP and occur more frequently in females,
with mutations of the APC gene beyond codon 1309 and with previous
abdominal surgery. We aimed to evaluate our management of patients
with FAP and desmoid tumours.
Method: Patients with FAP and desmoid tumours on our colorectal data-
base were identiﬁed. Information regarding APC mutation location and
clinical management were collected and analysed.
Result: There are 41 patients with FAP (25 female, 16 male), ten with
desmoid tumours. Median age at diagnosis was 33 (R ¼ 8e49). All had
undergone colectomy (eight prophylactically, two for malignancy). Three
abdominal wall desmoids were excised. Seven patients have been
managed conservatively with observation, chemoprophylaxis and ureteric
stenting for managing complications of compression. All patients have
been kept under surveillance. One patient died following bowel perfora-
tion and one from bowel obstruction. Genetic testing was performed on
the majority but speciﬁc mutational analysis was available for only 67% of
patients with FAP.
Conclusion: Our results show that our patients are being managed
appropriately but knowledge of location of germline mutation is strongly
advised prior to offering prophylactic colectomy and management of solid
desmoid tumours.http://dx.doi.org/10.1016/j.ijsu.2016.08.157
0770: SYSTEMATIC REVIEW AND META ANALYSIS OF PUBLISHED TRIALS
COMPARING THE EFFECTIVENESS OF TRANSANAL ENDOSCOPIC MICRO-
SURGERY TEMS AND ENDOSCPIC SUBMUCOSAL DISSECTION ESD IN THE
MANAGEMENT OF EARLY RECTAL CANCER T1,T2
Y. Rajjoub 1,*, N. Saffaf 2, H. Barr 1. 1Cheltenham General Hospital, Cheltenham,
UK; 2Birmingham Heartlands Hospital, Birmingham, UK.Aim: compare the safety and effectiveness of TEMS and ESD for early rectal
cancer.
Method: Electronic search of Medline, Embase, Pubmed , Up to date and
Chocrane Library was done.
Inclusion criteria: comparative published trials. Patients with early rectal
cancer T1, T2. Quality was assessed (Newcastle-Ottawa Scale and the
Cochrane Collaboration's Risk of bias tool). Revman 5.3 was used for sta-
tistical analysis .Odd Ratio with a 95% conﬁdence interval was calculated
for binary data. Standardizedmean difference with a 95% CI was calculated
for the continuous data .Heterogeneity was explored using Х2.
Result: Only two retrospective trials including 87 patients met the inclu-
sion criteria : Park et al. 2012, Kawaguti et al. 2013. There was a higher risk
of perforation with ESD .The En block resection rate was slightly higher
with ESD. The R0 Resection rate was almost the same between the two
groups. Operation timewas shorter in ESD group. No difference in the total
length of stay between two group. The recurrence was only reported in
Kawaguti trial and it was higher in ESD Group.Most TEMS patients needed
GA (86%), compared to ESD group 9 patients (22%).No mortality or
bleeding in both studies.
Conclusion: ESD is of slight higher perforation risk than TEMS. It was also
accompanied with small higher risk of recurrence.http://dx.doi.org/10.1016/j.ijsu.2016.08.158
0775: SYSTEMATIC REVIEW AND META-ANALYSIS OF MESH IMPLANTA-
TION DURING PRIMARY STOMA FORMATION TO PREVENT PARASTO-
MAL HERNIA
S.J. Chapman 1,*, B. Wood 1, T.M. Drake 2, N. Young 1, D.G. Jayne 1. 1University
of Leeds, Leeds, UK; 2University of Shefﬁeld, Shefﬁeld, UK.
Introduction: Parastomal hernia (PH) is common after gastrointestinal
stoma formation. Mesh implantation during primary surgery may reduce
the incidence of PH, but until recently the evidence has been limited to
few, low-volume randomised controlled trials (RCTs).
Method: MEDLINE, EMBASE and the Cochrane Library were searched be-
tween 2004-2015 for published RCTs testing mesh versus no mesh for
prevention of PH. Sixteen international trial registries were inspected for
ongoing trials. Meta analysis was performed on incidence of PH at least 12
months after stoma formation. Secondary outcomes included rates of
stoma-related complications and presence of ongoing trials.
Result: Of 2933 studies identiﬁed, 6 RCTs (380 patients) underwent meta-
analysis. All RCTs were high risk of bias. The incidence of PH was reduced
with mesh (10.8% versus 32.4%; P ¼ 0.001) (RR: 0.34, CI: 0.18e0.65,
I2 ¼ 39%). Mesh was associated with fewer repairs (2.1% versus 9.7%;
P ¼ 0.02) (RR: 0.33, CI: 0.13e0.82, I2 ¼ 0%) and did not increase the inci-
dence of stoma-related complications. Results from ongoing RCTs are
awaited, but few will assess newer mesh types or alternative surgical
techniques.
Conclusion: Mesh implantation at time of stoma formation appears safe
and effective in preventing PH. Low event rates and limitations of primary
evidence still implicate larger, more rigorous RCTs.http://dx.doi.org/10.1016/j.ijsu.2016.08.159
0791: QUANTIFYING QUALITY OF LIFE (QOL) OF PATIENTS TREATED
WITH BOTOX FOR CHRONIC ANAL FISSURE
A. Bagul*, F. McNicol, P. Carter. Royal Liverpool and Broadgreen University
Hospital, Liverpool, UK.
Background: Anal ﬁssures represent 10% of colorectal clinic referrals.
Chronicity is deﬁned as a ﬁssure persisting for >6 weeks despite medical
treatment. The hypothesis is that chronic ﬁssures have a raised resting anal
pressure from internal anal sphincter hypertonicity . Medical treatment is
ﬁrst line . Resistant cases are offered Botulinum Toxin or lateral internal
Sphincterotomy. Sphincterotomy produces good healing rates but is
associated with incontinence in up to 30% in long term follow up. Meta
Abstracts / International Journal of Surgery 36 (2016) S31eS132 S63analysis suggests medical treatment is safe for chronic anal ﬁssure and
reserves surgery for treatment failure.
Method: This observational study over 2 years analysed outcome mea-
sures on patient symptoms and QOL scores. The QOL scores were recorded
before and after respective procedure using SF 36 QOL Assessment Form .
Result: The median age was 48(28e77) years. 95.83% patients completed
the SF-36 form. This revealed that their quality of life improved signiﬁ-
cantly in physical functioning, pain, social functioning and mental health.
Conclusion: QOL data is rarely acquired in surgery so adds new knowledge
to the study by using available tools to assess QOL in patients undergoing
surgical treatment. Our study shows improvement in the QOL in patients
treated with Botox for chronic anal ﬁssure at follow up.http://dx.doi.org/10.1016/j.ijsu.2016.08.160
0830: EXTENDED VTE PROPHYLAXIS AFTER COLORECTAL CANCER SUR-
GERY e WHERE'S THE EVIDENCE?
C. Sproson 1,*, M. Lee 1, R. Kallam 2. 1 Shefﬁeld Teaching Hospitals NHS
Foundation Trust, South Yorkshire, UK; 2Northern Lincolnshire and Goole NHS
Foundation Trust, Lincolnshire, UK.
Background: NICE recommends extending pharmacological thrombo-
prophylaxis to 28-days postoperatively following abdominopelvic cancer
surgery. This is based on a 2009 Cochrane Review, which used data over a
decade old and compared extended thromboprophylaxis with placebo. In
current practice, where a minimum of in-hospital pharmacological
thromboprophylaxis is standard, is there evidence to support extended
prophylaxis following colorectal cancer surgery?
Aim: To report current incidence of post-discharge symptomatic VTE in
patients receiving only in-hospital pharmacological thromboprophylaxis
after colorectal cancer surgery.
Method: Two reviewers conducted a systematic review of the PubMed
Database using PRISMA guidelines. To ensure assessment of contemporary
data, only articles published after the 2009 Cochrane Review were
included.
Result: Initial search identiﬁed 50 abstracts. Final analysis included four
articles: one RCT and three retrospective cohorts. Data for 682 patients
revealed an incidence of 0.7% post-discharge symptomatic VTE at 30-days
post colorectal cancer surgery.
Conclusion: Current evidence suggests low incidence of post-discharge
symptomatic VTE following colorectal cancer surgery. The beneﬁt of
extending thromboprophylaxis is therefore questionable. In-hospital
thromboprophylaxis, enhanced recovery protocols and modern surgical
techniques have likely out-dated the evidence upon which national rec-
ommendations are based. Awell-powered RCT comparing in-hospital with
extended thromboprophylaxis is necessary to inform revised national
recommendations.http://dx.doi.org/10.1016/j.ijsu.2016.08.161
0871: EFFECTIVENESS OF THE BRITISH SOCIETY OF GASTROENTER-
OLOGY GUIDELINES FOR SURVEILLANCE COLONOSCOPIES ON COLONIC
ADENOMAS
S. Chandramoorthy 1,*, P. Soor 2, M. Wall 3, R. Ransford 2, E. Leung 3. 1Hull
York Medical School, York, UK; 2 St Georges University of London, London, UK;
3University of Birmingham, Birmingham, UK.
Introduction: The British Society of Gastroenterology (BSG) has set clear
guidelines on surveillance colonoscopy for adenomatous polyps. This
study aims to determine if these guidelines were adhered to in an
accredited unit.
Method: All patients who underwent surveillance colonoscopies between
October 2014 and 2015were retrospectively included. Information relating
to polyp number, size, and histology were collected and their subsequent
schedule colonoscopy was then compared with the BSG guidelines.Result: Out of the 106 cases detected, 62% (66/106) were not compliant to
the BSG guidelines (p>0.05). 49% (52/106) of the cases were requested by
gastroenterology of which 62% (32/52) were not compliant to the BSG
guidelines and on average were requested 35.4 months earlier than
scheduled. 51% (54/106) of the cases were requested by surgery of which
59% (32/54) were not compliant to the BSG guidelines and on averagewere
requested 36.5 months earlier than scheduled.
Conclusion: Too many surveillance colonoscopies were performed in our
unit and in around 60% cases nearly three years earlier than required.
Targeting the reasons for non-compliance could potentially reduce work-
load and improve efﬁciency in an over-stretched colonoscopy unit.http://dx.doi.org/10.1016/j.ijsu.2016.08.162
0883: OUTCOMES OF EMERGENCY LAPAROSCOPIC COLONIC RESEC-
TION: A SINGLE CENTRE EXPERIENCE
K. Mccoll 2,*, A. Amer 1, P. Ainley 1, K. Shahi 1, D. Borowski 1, D. Garg 1. 1North
Tees and Hartlepool NHS Foundation Trust, Stockton on Tees, UK; 2Newcastle
University, Newcastle upon Tyne, UK.
Introduction: Laparoscopic colonic resection in the emergency setting has
not been met with comparable enthusiasm as that in the elective setting.
We describe the 5-year experience of emergency laparoscopic colonic
resection at a single colorectal unit.
Method: Data for emergency laparoscopic colonic resections was collected
from a prospectively-maintained database for a single surgeon at a colo-
rectal unit between 2010e2015. Outcomes were compared to average data
for emergency open colonic resection within the department.
Result: A total of 66 patients were included in this studywith amedian age
of 62 years. Average operating time was 190 minutes (compared to 144
minutes for open emergency resections). The conversion rate to open
resectionwas 9%. Intraoperative complications occurred in 6% of cases and
included bleeding and bowel injury. Postoperative complications (30-day)
were mainly infective and occurred in 13.6% of cases. No anastomotic leaks
were identiﬁed in this cohort. Median postoperative stay was 6 days
compared to 7 days for open surgery. For malignant colonic pathology, R1
resections occurred in 9.5% of cases and median lymph node yield was 20.
Conclusion: Our data conﬁrms the feasibility and safety of colonic resec-
tion surgery in the emergency setting for benign and malignant disease.http://dx.doi.org/10.1016/j.ijsu.2016.08.163
0910: THE INCIDENCE AND IMPLICATIONS OF INTESTINAL INJURY IN
LAPAROSCOPIC COLORECTAL SURGERY
P. Chaichanavichkij*, T. Killeen, K. Aryal. James Paget University Hospitals
NHS Foundation Trust, Great Yarmouth, UK.
Aim: Intestinal injury (II) is a recognised complication of laparoscopic
surgery in general, there is little evidence on the actual incidence of II in
laparoscopic colorectal surgery (LCS). This study investigates the incidence
and consequences of II in LCS.
Method: A systematic literature search was conducted through PubMed,
Ovid, and the Cochrane Database to identify primary studies in the English
Language which reported incidence of II in LCS for benign and malignant
diseases between January 2000 and October 2015. Information on de-
mographics, operative characteristics, previous abdominal surgery, con-
version rate, and II was extracted from the selected studies.
Result: Forty-three studies were included, pertaining to 29600 patients.
The overall intra-operative complication rate was 5.7% (n ¼ 1297/22931),
conversion rate was 8.6% (n ¼ 2351/27368), and mortality rate was 1.0%
(n ¼ 297/28943).
II occurred in 365 patients (1.2%) and forms 28.1% of all intra-operative
complications. The majority of injuries were diagnosed intra-operatively
(98.6%, n¼ 360), ofwhich11.4% (n¼ 41) required conversion toopen surgery.
Among the 1.4% (n ¼ 5) of II diagnosed post-operatively, 60% (n ¼ 3) died.
